We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Oncology

Journal Scan / Research · July 19, 2018

Value of Bone Marrow Biopsy in Hodgkin's Lymphoma Patients Staged by FDG-PET

Annals of Oncology


Additional Info

Annals of Oncology
Value of Bone Marrow Biopsy in Hodgkin Lymphoma Patients Staged by FDG PET: Results From the German Hodgkin Study Group Trials HD16, HD17, and HD18
Ann. Oncol 2018 Jul 13;[EPub Ahead of Print], C-A Voltin, H Goergen, C Baues, M Fuchs, J Mettler, S Kreissl, J Oertl, B Klaeser, A Moccia, A Drzezga, A Engert, P Borchmann, M Dietlein, C Kobe

Further Reading